Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children’s Hospital, Houston, Texas
Background.
Cases of pyomyositis and myositis have been increasing in frequency at Texas Children’s Hospital (Houston) since 2000. The increase appears to correlate with the emergence of community‐acquired methicillin‐resistant Staphylococcus aureus (MRSA).
Methods.
The medical records of patients with pyomyositis and myositis hospitalized at Texas Children’s Hospital during the period from January 2000 through December 2005 were reviewed. Available S. aureus isolates were obtained for susceptibility testing, to determine the presence of pvl (lukS‐PV and lukF‐PV), and for pulsed‐field gel electrophoresis analysis.
Results.
Forty‐five previously healthy children with bacterial pyomyositis or myositis were analyzed. The causes were S. aureus (in 57.8% of children) and Streptococcus pyogenes (in 2.2%); 40.0% of children had negative culture results. The number of cases increased between 2000 and 2005, primarily as a result of an increase in the prevalence of community‐acquired MRSA. The mean patient age was 5.5 years (range, 0.06–15 years). The thigh (40.0% of children) and pelvis (28.9%) were the most commonly affected sites. The mean abscess diameter was 3.5 cm. Eighteen children required at least 1 muscle drainage procedure. Of the 24 available S. aureus isolates (15 community‐acquired MRSA isolates and 9 community‐acquired, methicillin‐susceptible S. aureus [MSSA] isolates), 16 were found to be USA300 by pulsed‐field gel electrophoresis, and 17 carried pvl. Patients with community‐acquired MRSA, USA300, and/or pvl‐positive strains required more drainage procedures than did those with community‐acquired MSSA, non‐USA300, and/or pvl‐negative strains (81% vs. 40% [
], 82% vs. 29% [
], and 81% vs. 38% [
], respectively).
Conclusions.
Community‐acquired MRSA is an increasing cause of pyomyositis and myositis in children. Community‐acquired MRSA, USA300, pvl‐positive S. aureus isolates caused more severe disease than did community‐acquired MSSA, non‐USA300, and pvl‐negative isolates, respectively.
Cited by
GEORGE Y. LIU. (2009) Molecular Pathogenesis of Staphylococcus aureus Infection.
Pediatric Research 65:Supplement, 71R-77R
Online publication date: 1-Jun-2009.
CrossRef Mukesh Patel. (2009) Community-Associated Meticillin-Resistant Staphylococcus aureus Infections.
Drugs 69:6, 693-716
Online publication date: 1-Feb-2009.
CrossRef Bruce M. Lo, Benjamin A. Fickenscher. (2009) Primary pyomyositis caused by ca-MRSA.
International Journal of Emergency Medicine 1:4, 331-332
Online publication date: 1-Jan-2009.
CrossRef Y.-C. Huang, C.-F. Ho, C.-J. Chen, L.-H. Su, T.-Y. Lin. (2009) Comparative molecular analysis of community-associated and healthcare-associated methicillin-resistant
Staphylococcus aureus
isolates from children in northern Taiwan.
Clinical Microbiology and Infection 14:12, 1167-1172
Online publication date: 1-Jan-2009.
CrossRef Sheldon L. Kaplan. (2008) COMMENTARY: PREVENTION OF RECURRENT STAPHYLOCOCCAL INFECTIONS.
The Pediatric Infectious Disease Journal 27:10, 935-937
Online publication date: 1-Nov-2008.
CrossRef Blanca E. Gonzalez, Sheldon L. Kaplan. (2008) Severe Staphylococcal Infections in Children.
Pediatric Annals 37:10, 686-693
Online publication date: 1-Nov-2008.
CrossRef A. Ramos, L. Ley, E. Muñez, A. Videl, I. Sánchez. (2008) Brain Abscess due to Panton–Valentine Leukocidin-Positive Staphylococcus aureus.
Infection Online publication date: 25-Sep-2008.
CrossRef Lorna P. Browne, Edward O. Mason, Sheldon L. Kaplan, Christopher I. Cassady, Rajesh Krishnamurthy, R. Paul Guillerman. (2008) Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children.
Pediatric Radiology 38:8, 841-847
Online publication date: 1-Sep-2008.
CrossRef Michelle J. Sunga, Sy Teisan, Ginger Tsueng, Venkat R. Macherla, Kin S. Lam. (2008) Seawater requirement for the production of lipoxazolidinones by marine actinomycete strain NPS8920.
Journal of Industrial Microbiology & Biotechnology 35:7, 761-765
Online publication date: 1-Aug-2008.
CrossRef Edina Avdic, Sara E Cosgrove. (2008) Management and control strategies for community-associated methicillin-resistant
Staphylococcus aureus.
Expert Opinion on Pharmacotherapy 9:9, 1463-1479
Online publication date: 1-Jul-2008.
CrossRef Helen W. Boucher and G. Ralph Corey. (2008) Epidemiology of Methicillin‐Resistant
Staphylococcus aureus.
Clinical Infectious Diseases 46:s5, S344-S349
Online publication date: 1-Jun-2008.
Martin E. Stryjewski and Henry F. Chambers. (2008) Skin and Soft‐Tissue Infections Caused by Community‐Acquired Methicillin‐Resistant
Staphylococcus aureus.
Clinical Infectious Diseases 46:s5, S368-S377
Online publication date: 1-Jun-2008.
Michael Z. David, Daniel Glikman, Susan E. Crawford, Jie Peng, Kimberly J. King, Mark A. Hostetler, Susan Boyle‐Vavra, and Robert S. Daum. (2008) What Is Community‐Associated Methicillin‐Resistant
Staphylococcus aureus?.
The Journal of Infectious Diseases 197:9, 1235-1243
Online publication date: 1-May-2008.
Louis B. Rice, John G. Bartlett, Donald E. Craven, Dennis L. Stevens, Robert C. Moellering, George M. Eliopoulos. (2008) Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy.
Infectious Diseases in Clinical Practice 16:Suppl. 1, S1-S20
Online publication date: 1-Apr-2008.
CrossRef Loren G. Miller and Binh An Diep. (2008) Clinical Practice: Colonization, Fomites, and Virulence: Rethinking the Pathogenesis of Community‐Associated Methicillin‐Resistant
Staphylococcus aureus Infection.
Clinical Infectious Diseases 46:5, 752-760
Online publication date: 1-Mar-2008.
Brendan J. Kilbane, Sally L. Reynolds. (2008) Emergency Department Management of Community-Acquired Methicillin-Resistant Staphylococcus aureus.
Pediatric Emergency Care 24:2, 109-114
Online publication date: 1-Mar-2008.
CrossRef Jason G Newland, Gregory L Kearns. (2008) Treatment Strategies for Methicillin-Resistant Staphylococcus aureus Infections in Pediatrics.
Pediatric Drugs 10:6, 367-378
Online publication date: 1-Feb-2008.
CrossRef Rachel J. Gorwitz. (2008) A Review of Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections.
The Pediatric Infectious Disease Journal 27:1, 1-7
Online publication date: 1-Feb-2008.
CrossRef Rachel J. Gorwitz. (2008) Understanding the Success of Methicillin‐Resistant
Staphylococcus aureus Strains Causing Epidemic Disease in the Community.
The Journal of Infectious Diseases 197:2, 179-182
Online publication date: 15-Jan-2008.
Michelle L. McCaskill, Edward O. Mason, Sheldon L. Kaplan, Wendy Hammerman, Linda B. Lamberth, Kristina G. Hultén. (2008) Increase of the USA300 Clone Among Community-Acquired Methicillin-Susceptible Staphylococcus aureus Causing Invasive Infections.
The Pediatric Infectious Disease Journal 26:12, 1122-1127
Online publication date: 1-Jan-2008.
CrossRef Stephanie M. Hamilton, Amy E. Bryant, Karen C. Carroll, Vivian Lockary, Yongsheng Ma, Eric McIndoo, Loren G. Miller, Francoise Perdreau‐Remington, John Pullman, George F. Risi, Daniel B. Salmi, and Dennis L. Stevens. (2007) In Vitro Production of Panton‐Valentine Leukocidin among Strains of Methicillin‐Resistant
Staphylococcus aureus Causing Diverse Infections.
Clinical Infectious Diseases 45:12, 1550-1558
Online publication date: 15-Dec-2007.
Susan I Gerber. (2006) Describing the methicillin-resistant <i>Staphylococcus aureus</i> epidemic: a public health challenge.
Expert Review of Anti-infective Therapy 4:6, 905
CrossRef